Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 17 studies | 32% ± 11% | |
basal cell | 8 studies | 31% ± 9% | |
endothelial cell | 6 studies | 21% ± 3% | |
epithelial cell | 6 studies | 36% ± 12% | |
fibroblast | 5 studies | 28% ± 9% | |
secretory cell | 5 studies | 32% ± 6% | |
pancreatic A cell | 4 studies | 43% ± 15% | |
endothelial cell of vascular tree | 4 studies | 36% ± 16% | |
type B pancreatic cell | 3 studies | 41% ± 13% | |
adipocyte | 3 studies | 25% ± 3% | |
hepatocyte | 3 studies | 55% ± 27% | |
luminal cell of prostate epithelium | 3 studies | 25% ± 7% | |
smooth muscle cell | 3 studies | 20% ± 5% | |
GABAergic neuron | 3 studies | 39% ± 9% | |
glutamatergic neuron | 3 studies | 49% ± 12% | |
pancreatic ductal cell | 3 studies | 35% ± 14% | |
enteroendocrine cell | 3 studies | 25% ± 3% | |
erythrocyte | 3 studies | 27% ± 6% | |
astrocyte | 3 studies | 22% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 1508.02 | 575 / 578 | 100% | 58.40 | 1155 / 1155 |
liver | 100% | 1910.01 | 226 / 226 | 99% | 34.30 | 402 / 406 |
breast | 100% | 1398.89 | 459 / 459 | 99% | 20.28 | 1102 / 1118 |
thymus | 100% | 2079.94 | 653 / 653 | 98% | 25.54 | 590 / 605 |
esophagus | 97% | 917.94 | 1408 / 1445 | 100% | 61.76 | 183 / 183 |
bladder | 100% | 1137.43 | 21 / 21 | 97% | 31.41 | 489 / 504 |
brain | 99% | 995.86 | 2608 / 2642 | 98% | 12.79 | 691 / 705 |
stomach | 97% | 910.87 | 349 / 359 | 98% | 16.76 | 281 / 286 |
prostate | 100% | 880.94 | 244 / 245 | 96% | 12.00 | 480 / 502 |
kidney | 100% | 1467.78 | 89 / 89 | 95% | 18.29 | 857 / 901 |
uterus | 98% | 562.12 | 166 / 170 | 97% | 24.36 | 446 / 459 |
intestine | 96% | 840.09 | 930 / 966 | 98% | 15.44 | 519 / 527 |
ovary | 94% | 569.11 | 170 / 180 | 99% | 16.48 | 427 / 430 |
adrenal gland | 100% | 3066.76 | 258 / 258 | 91% | 11.19 | 209 / 230 |
pancreas | 92% | 523.82 | 303 / 328 | 97% | 15.62 | 172 / 178 |
skin | 92% | 1271.49 | 1669 / 1809 | 84% | 8.83 | 398 / 472 |
adipose | 100% | 1751.00 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 2234.53 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1061.10 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.37 | 1 / 1 |
blood vessel | 99% | 823.78 | 1319 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 34.59 | 44 / 45 |
peripheral blood | 90% | 907.42 | 839 / 929 | 0% | 0 | 0 / 0 |
heart | 89% | 598.28 | 764 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 76% | 6.17 | 22 / 29 |
eye | 0% | 0 | 0 / 0 | 31% | 2.06 | 25 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007584 | Biological process | response to nutrient |
GO_0071333 | Biological process | cellular response to glucose stimulus |
GO_0035229 | Biological process | positive regulation of glutamate-cysteine ligase activity |
GO_0006534 | Biological process | cysteine metabolic process |
GO_0071372 | Biological process | cellular response to follicle-stimulating hormone stimulus |
GO_0035729 | Biological process | cellular response to hepatocyte growth factor stimulus |
GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
GO_0051409 | Biological process | response to nitrosative stress |
GO_0014823 | Biological process | response to activity |
GO_0006750 | Biological process | glutathione biosynthetic process |
GO_0097746 | Biological process | blood vessel diameter maintenance |
GO_0006536 | Biological process | glutamate metabolic process |
GO_0008637 | Biological process | apoptotic mitochondrial changes |
GO_0051900 | Biological process | regulation of mitochondrial depolarization |
GO_0097069 | Biological process | cellular response to thyroxine stimulus |
GO_2001237 | Biological process | negative regulation of extrinsic apoptotic signaling pathway |
GO_0044752 | Biological process | response to human chorionic gonadotropin |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0006979 | Biological process | response to oxidative stress |
GO_0044344 | Biological process | cellular response to fibroblast growth factor stimulus |
GO_0035733 | Biological process | hepatic stellate cell activation |
GO_0005829 | Cellular component | cytosol |
GO_0017109 | Cellular component | glutamate-cysteine ligase complex |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0035226 | Molecular function | glutamate-cysteine ligase catalytic subunit binding |
GO_0004357 | Molecular function | glutamate-cysteine ligase activity |
GO_0030234 | Molecular function | enzyme regulator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | GCLM |
Protein name | Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit) |
Synonyms | GLCLR |
Description | |
Accessions | ENST00000615724.1 [P48507-2] ENST00000370238.8 [P48507-1] P48507 |